928 related articles for article (PubMed ID: 29446198)
1. Mutational spectrum in a worldwide study of 29,700 families with BRCA1 or BRCA2 mutations.
Rebbeck TR; Friebel TM; Friedman E; Hamann U; Huo D; Kwong A; Olah E; Olopade OI; Solano AR; Teo SH; Thomassen M; Weitzel JN; Chan TL; Couch FJ; Goldgar DE; Kruse TA; Palmero EI; Park SK; Torres D; van Rensburg EJ; McGuffog L; Parsons MT; Leslie G; Aalfs CM; Abugattas J; Adlard J; Agata S; Aittomäki K; Andrews L; Andrulis IL; Arason A; Arnold N; Arun BK; Asseryanis E; Auerbach L; Azzollini J; Balmaña J; Barile M; Barkardottir RB; Barrowdale D; Benitez J; Berger A; Berger R; Blanco AM; Blazer KR; Blok MJ; Bonadona V; Bonanni B; Bradbury AR; Brewer C; Buecher B; Buys SS; Caldes T; Caliebe A; Caligo MA; Campbell I; Caputo SM; Chiquette J; Chung WK; Claes KBM; Collée JM; Cook J; Davidson R; de la Hoya M; De Leeneer K; de Pauw A; Delnatte C; Diez O; Ding YC; Ditsch N; Domchek SM; Dorfling CM; Velazquez C; Dworniczak B; Eason J; Easton DF; Eeles R; Ehrencrona H; Ejlertsen B; ; Engel C; Engert S; Evans DG; Faivre L; Feliubadaló L; Ferrer SF; Foretova L; Fowler J; Frost D; Galvão HCR; Ganz PA; Garber J; Gauthier-Villars M; Gehrig A; ; Gerdes AM; Gesta P; Giannini G; Giraud S; Glendon G; Godwin AK; Greene MH; Gronwald J; Gutierrez-Barrera A; Hahnen E; Hauke J; ; Henderson A; Hentschel J; Hogervorst FBL; Honisch E; Imyanitov EN; Isaacs C; Izatt L; Izquierdo A; Jakubowska A; James P; Janavicius R; Jensen UB; John EM; Vijai J; Kaczmarek K; Karlan BY; Kast K; Investigators K; Kim SW; Konstantopoulou I; Korach J; Laitman Y; Lasa A; Lasset C; Lázaro C; Lee A; Lee MH; Lester J; Lesueur F; Liljegren A; Lindor NM; Longy M; Loud JT; Lu KH; Lubinski J; Machackova E; Manoukian S; Mari V; Martínez-Bouzas C; Matrai Z; Mebirouk N; Meijers-Heijboer HEJ; Meindl A; Mensenkamp AR; Mickys U; Miller A; Montagna M; Moysich KB; Mulligan AM; Musinsky J; Neuhausen SL; Nevanlinna H; Ngeow J; Nguyen HP; Niederacher D; Nielsen HR; Nielsen FC; Nussbaum RL; Offit K; Öfverholm A; Ong KR; Osorio A; Papi L; Papp J; Pasini B; Pedersen IS; Peixoto A; Peruga N; Peterlongo P; Pohl E; Pradhan N; Prajzendanc K; Prieur F; Pujol P; Radice P; Ramus SJ; Rantala J; Rashid MU; Rhiem K; Robson M; Rodriguez GC; Rogers MT; Rudaitis V; Schmidt AY; Schmutzler RK; Senter L; Shah PD; Sharma P; Side LE; Simard J; Singer CF; Skytte AB; Slavin TP; Snape K; Sobol H; Southey M; Steele L; Steinemann D; Sukiennicki G; Sutter C; Szabo CI; Tan YY; Teixeira MR; Terry MB; Teulé A; Thomas A; Thull DL; Tischkowitz M; Tognazzo S; Toland AE; Topka S; Trainer AH; Tung N; van Asperen CJ; van der Hout AH; van der Kolk LE; van der Luijt RB; Van Heetvelde M; Varesco L; Varon-Mateeva R; Vega A; Villarreal-Garza C; von Wachenfeldt A; Walker L; Wang-Gohrke S; Wappenschmidt B; Weber BHF; Yannoukakos D; Yoon SY; Zanzottera C; Zidan J; Zorn KK; Hutten Selkirk CG; Hulick PJ; Chenevix-Trench G; Spurdle AB; Antoniou AC; Nathanson KL
Hum Mutat; 2018 May; 39(5):593-620. PubMed ID: 29446198
[TBL] [Abstract][Full Text] [Related]
2. Identification of BRCA1/2 founder mutations in Southern Chinese breast cancer patients using gene sequencing and high resolution DNA melting analysis.
Kwong A; Ng EK; Wong CL; Law FB; Au T; Wong HN; Kurian AW; West DW; Ford JM; Ma ES
PLoS One; 2012; 7(9):e43994. PubMed ID: 22970155
[TBL] [Abstract][Full Text] [Related]
3. Mutational analysis of BRCA1 and BRCA2 and clinicopathologic analysis of ovarian cancer in 82 ovarian cancer families: two common founder mutations of BRCA1 in Japanese population.
Sekine M; Nagata H; Tsuji S; Hirai Y; Fujimoto S; Hatae M; Kobayashi I; Fujii T; Nagata I; Ushijima K; Obata K; Suzuki M; Yoshinaga M; Umesaki N; Satoh S; Enomoto T; Motoyama S; Tanaka K;
Clin Cancer Res; 2001 Oct; 7(10):3144-50. PubMed ID: 11595708
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of BRCA1 and BRCA2 mutation prevalence, risk prediction models and a multistep testing approach in French-Canadian families with high risk of breast and ovarian cancer.
Simard J; Dumont M; Moisan AM; Gaborieau V; Malouin H; Durocher F; Chiquette J; Plante M; Avard D; Bessette P; Brousseau C; Dorval M; Godard B; Houde L; ; Joly Y; Lajoie MA; Leblanc G; Lépine J; Lespérance B; Vézina H; Parboosingh J; Pichette R; Provencher L; Rhéaume J; Sinnett D; Samson C; Simard JC; Tranchant M; Voyer P; Easton D; Tavtigian SV; Knoppers BM; Laframboise R; Bridge P; Goldgar D
J Med Genet; 2007 Feb; 44(2):107-21. PubMed ID: 16905680
[TBL] [Abstract][Full Text] [Related]
5. Statewide Retrospective Review of Familial Pancreatic Cancer in Delaware, and Frequency of Genetic Mutations in Pancreatic Cancer Kindreds.
Catts ZA; Baig MK; Milewski B; Keywan C; Guarino M; Petrelli N
Ann Surg Oncol; 2016 May; 23(5):1729-35. PubMed ID: 26727920
[TBL] [Abstract][Full Text] [Related]
6. Increased prevalence of the founder BRCA1 c.5309G>T and recurrent BRCA2 c.1310_1313delAAGA mutations in breast cancer families from Northerstern region of Morocco: evidence of geographical specificity and high relevance for genetic counseling.
Melki R; Melloul M; Aissaoui S; El Harroudi T; Boukhatem N
BMC Cancer; 2023 Apr; 23(1):339. PubMed ID: 37055759
[TBL] [Abstract][Full Text] [Related]
7. Prevalence of BRCA1 and BRCA2 mutations in Pakistani breast and ovarian cancer patients.
Rashid MU; Zaidi A; Torres D; Sultan F; Benner A; Naqvi B; Shakoori AR; Seidel-Renkert A; Farooq H; Narod S; Amin A; Hamann U
Int J Cancer; 2006 Dec; 119(12):2832-9. PubMed ID: 16998791
[TBL] [Abstract][Full Text] [Related]
8. The spectrum of BRCA1 and BRCA2 pathogenic sequence variants in Middle Eastern, North African, and South European countries.
Laitman Y; Friebel TM; Yannoukakos D; Fostira F; Konstantopoulou I; Figlioli G; Bonanni B; Manoukian S; Zuradelli M; Tondini C; Pasini B; Peterlongo P; Plaseska-Karanfilska D; Jakimovska M; Majidzadeh K; Zarinfam S; Loizidou MA; Hadjisavvas A; Michailidou K; Kyriacou K; Behar DM; Molho RB; Ganz P; James P; Parsons MT; Sallam A; Olopade OI; Seth A; Chenevix-Trench G; Leslie G; McGuffog L; Marafie MJ; Megarbane A; Al-Mulla F; Rebbeck TR; Friedman E
Hum Mutat; 2019 Nov; 40(11):e1-e23. PubMed ID: 31209999
[TBL] [Abstract][Full Text] [Related]
9. The yield of targeted genotyping for the recurring mutations in BRCA1/2 in Israel.
Bernstein-Molho R; Laitman Y; Schayek H; Reish O; Lotan S; Haim S; Zidan J; Friedman E
Breast Cancer Res Treat; 2018 Feb; 167(3):697-702. PubMed ID: 29086229
[TBL] [Abstract][Full Text] [Related]
10. BRCA1 and BRCA2 mutations in ovarian cancer patients from China: ethnic-related mutations in BRCA1 associated with an increased risk of ovarian cancer.
Shi T; Wang P; Xie C; Yin S; Shi D; Wei C; Tang W; Jiang R; Cheng X; Wei Q; Wang Q; Zang R
Int J Cancer; 2017 May; 140(9):2051-2059. PubMed ID: 28176296
[TBL] [Abstract][Full Text] [Related]
11. Genetic testing in Poland and Ukraine: should comprehensive germline testing of
Nguyen-Dumont T; Karpinski P; Sasiadek MM; Akopyan H; Steen JA; Theys D; Hammet F; Tsimiklis H; Park DJ; Pope BJ; Slezak R; Stembalska A; Pesz K; Kitsera N; Siekierzynska A; Southey MC; Myszka A
Genet Res (Camb); 2020 Aug; 102():e6. PubMed ID: 32772980
[TBL] [Abstract][Full Text] [Related]
12. BRCA1 and BRCA2 Germline Mutation Analysis in Hereditary Breast/Ovarian Cancer Families from the Aures Region (Eastern Algeria): First Report.
Mehemmai C; Cherbal F; Hamdi Y; Guedioura A; Benbrahim W; Bakour R; Abdelhak S
Pathol Oncol Res; 2020 Apr; 26(2):715-726. PubMed ID: 30715675
[TBL] [Abstract][Full Text] [Related]
13. Tracking of the origin of recurrent mutations of the BRCA1 and BRCA2 genes in the North-East of Italy and improved mutation analysis strategy.
Cini G; Mezzavilla M; Della Puppa L; Cupelli E; Fornasin A; D'Elia AV; Dolcetti R; Damante G; Bertok S; Miolo G; Maestro R; de Paoli P; Amoroso A; Viel A
BMC Med Genet; 2016 Feb; 17():11. PubMed ID: 26852130
[TBL] [Abstract][Full Text] [Related]
14. Founder mutations in BRCA1 and BRCA2 genes.
Ferla R; Calò V; Cascio S; Rinaldi G; Badalamenti G; Carreca I; Surmacz E; Colucci G; Bazan V; Russo A
Ann Oncol; 2007 Jun; 18 Suppl 6():vi93-8. PubMed ID: 17591843
[TBL] [Abstract][Full Text] [Related]
15. Characterization of the Cancer Spectrum in Men With Germline BRCA1 and BRCA2 Pathogenic Variants: Results From the Consortium of Investigators of Modifiers of BRCA1/2 (CIMBA).
Silvestri V; Leslie G; Barnes DR; ; Agnarsson BA; Aittomäki K; Alducci E; Andrulis IL; Barkardottir RB; Barroso A; Barrowdale D; Benitez J; Bonanni B; Borg A; Buys SS; Caldés T; Caligo MA; Capalbo C; Campbell I; Chung WK; Claes KBM; Colonna SV; Cortesi L; Couch FJ; de la Hoya M; Diez O; Ding YC; Domchek S; Easton DF; Ejlertsen B; Engel C; Evans DG; Feliubadalò L; Foretova L; Fostira F; Géczi L; Gerdes AM; Glendon G; Godwin AK; Goldgar DE; Hahnen E; Hogervorst FBL; Hopper JL; Hulick PJ; Isaacs C; Izquierdo A; James PA; Janavicius R; Jensen UB; John EM; Joseph V; Konstantopoulou I; Kurian AW; Kwong A; Landucci E; Lesueur F; Loud JT; Machackova E; Mai PL; Majidzadeh-A K; Manoukian S; Montagna M; Moserle L; Mulligan AM; Nathanson KL; Nevanlinna H; Ngeow J; Nikitina-Zake L; Offit K; Olah E; Olopade OI; Osorio A; Papi L; Park SK; Pedersen IS; Perez-Segura P; Petersen AH; Pinto P; Porfirio B; Pujana MA; Radice P; Rantala J; Rashid MU; Rosenzweig B; Rossing M; Santamariña M; Schmutzler RK; Senter L; Simard J; Singer CF; Solano AR; Southey MC; Steele L; Steinsnyder Z; Stoppa-Lyonnet D; Tan YY; Teixeira MR; Teo SH; Terry MB; Thomassen M; Toland AE; Torres-Esquius S; Tung N; van Asperen CJ; Vega A; Viel A; Vierstraete J; Wappenschmidt B; Weitzel JN; Wieme G; Yoon SY; Zorn KK; McGuffog L; Parsons MT; Hamann U; Greene MH; Kirk JA; Neuhausen SL; Rebbeck TR; Tischkowitz M; Chenevix-Trench G; Antoniou AC; Friedman E; Ottini L
JAMA Oncol; 2020 Aug; 6(8):1218-1230. PubMed ID: 32614418
[TBL] [Abstract][Full Text] [Related]
16. Contribution of BRCA1 and BRCA2 mutations to inherited ovarian cancer.
Ramus SJ; Harrington PA; Pye C; DiCioccio RA; Cox MJ; Garlinghouse-Jones K; Oakley-Girvan I; Jacobs IJ; Hardy RM; Whittemore AS; Ponder BA; Piver MS; Pharoah PD; Gayther SA
Hum Mutat; 2007 Dec; 28(12):1207-15. PubMed ID: 17688236
[TBL] [Abstract][Full Text] [Related]
17. Spectrum and characterisation of BRCA1 and BRCA2 deleterious mutations in high-risk Czech patients with breast and/or ovarian cancer.
Machackova E; Foretova L; Lukesova M; Vasickova P; Navratilova M; Coene I; Pavlu H; Kosinova V; Kuklova J; Claes K
BMC Cancer; 2008 May; 8():140. PubMed ID: 18489799
[TBL] [Abstract][Full Text] [Related]
18. BRCA1 and BRCA2 mutations in the ovarian cancer population across race and ethnicity: special reference to Asia.
Shanmughapriya S; Nachiappan V; Natarajaseenivasan K
Oncology; 2013; 84(4):226-32. PubMed ID: 23364291
[TBL] [Abstract][Full Text] [Related]
19. Low Prevalence of the Four Common Colombian Founder Mutations in
Vargas E; Torres Lopez DM; de Deugd R; Gil F; Nova A; Mora L; Viaña LF; Hernandez JD; Bruges R; Hamann U
Oncologist; 2019 Jul; 24(7):e475-e479. PubMed ID: 30541753
[TBL] [Abstract][Full Text] [Related]
20. Analysis of breast cancer susceptibility genes BRCA1 and BRCA2 in Thai familial and isolated early-onset breast and ovarian cancer.
Patmasiriwat P; Bhothisuwan K; Sinilnikova OM; Chopin S; Methakijvaroon S; Badzioch M; Padungsutt P; Vattanaviboon P; Vattanasapt V; Szabo C; Saunders GF; Goldgar D; Lenoir GM
Hum Mutat; 2002 Sep; 20(3):230. PubMed ID: 12203997
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
